Health Canada safety review finds link between the use of Xeljanz and Xeljanz XR (tofacitinib) and increased risk of serious heart-related issues and cancer

Product Xeljanz and Xeljanz XR (tofacitinib), a prescription drug used to treat rheumatoid arthritis, psoriatic arthritis and ulcerative colitis. Issue Health products - Product safety What to do Do not stop or change your dose of Xeljanz or Xeljanz XR (tofacitinib) without first talking to your health care professional. Audience Health professionals

Product safety

Xeljanz and Xeljanz XR (tofacitinib), a prescription drug used to treat rheumatoid arthritis, psoriatic arthritis and ulcerative colitis.

RA-62311